,OR,p,FDR
Waist-to-hip ratio adjusted for BMI in non-smokers,26.279678068410462,0.00031761840682551027,False
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),25.083226632522408,0.00035947533045255773,False
Asthma,4.362111013559653,0.0018563994348405706,False
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),12.520486555697824,0.002319371675013351,False
Red cell distribution width,2.8719907407407406,0.004826356500115401,False
Waist circumference adjusted for body mass index,2.6670407458563536,0.007760984552778577,False
Selective IgA deficiency,12.950396825396826,0.01226359001985295,False
Age-related disease endophenotypes,12.085185185185185,0.013882625252299653,False
Respiratory diseases,5.9660134721371705,0.016343163019564243,False
Asthma onset (childhood vs adult),10.354761904761904,0.01830752260332906,False
Parental longevity (combined parental age at death),9.056944444444444,0.023245584522033753,False
"Age-related diseases, mortality and associated endophenotypes",9.056944444444444,0.023245584522033753,False
Mean corpuscular volume,3.230571125587032,0.02417978135769857,False
Family history of Alzheimer's disease,8.231060606060606,0.02754452045509561,False
Type 2 diabetes (adjusted for BMI),8.047530864197531,0.028665638178882687,False
Psoriasis,4.764360073484385,0.028770972293003287,False
Eosinophil counts,2.288661692917012,0.032979986388041956,False
Red blood cell count,2.160210855134713,0.03412337161598208,False
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),6.347465886939571,0.04346412557008127,False
High light scatter reticulocyte percentage of red cells,3.9344411794508054,0.04581599028771171,False
Tonsillectomy,3.9060362173038228,0.046614428544663584,False
Mouth ulcers,6.0287037037037035,0.047525194804662343,False
Reticulocyte count,3.8232049640500345,0.04905110387792613,False
Reticulocyte fraction of red cells,3.7698882952889754,0.05070981002907424,False
High light scatter reticulocyte count,3.7698882952889754,0.05070981002907424,False
Keratinocyte cancer (MTAG),5.740299823633157,0.05171937435985425,False
Pre-treatment viral load in HIV-1 infection,5.650173611111111,0.05314606353380099,False
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab),19.898021308980212,0.05486381019583459,False
Cutaneous psoriasis,19.898021308980212,0.05486381019583459,False
Non-alcoholic fatty liver disease histology (lobular),19.898021308980212,0.05486381019583459,False
Bipolar disorder with mood-incongruent psychosis,19.898021308980212,0.05486381019583459,False
Temperament,19.898021308980212,0.05486381019583459,False
Eosinophil percentage of white cells,3.6184124615241116,0.05584839151517732,False
Bitter alcoholic beverage consumption,5.478114478114478,0.05604118730470098,False
Sum eosinophil basophil counts,3.478514398492868,0.06122664509616901,False
Alzheimer's disease,5.163492063492064,0.061992944465017824,False
Prostate cancer (early onset),16.277708592777085,0.06547477534732749,False
"Facial morphology (factor 11, projection of the nose)",16.277708592777085,0.06547477534732749,False
Western dietary pattern,16.277708592777085,0.06547477534732749,False
Alzheimer's disease or family history of Alzheimer's disease,4.817407407407408,0.06971976756309942,False
Waist-to-hip ratio adjusted for body mass index,4.817407407407408,0.06971976756309942,False
Mortality in sepsis,14.920091324200913,0.07073610117136539,False
Plasma anti-thyroid peroxidase levels,14.920091324200913,0.07073610117136539,False
Alzheimer's disease (onset between ages 58 and 79),14.920091324200913,0.07073610117136539,False
Alzheimer's disease or HDL levels (pleiotropy),14.920091324200913,0.07073610117136539,False
Mean corpuscular hemoglobin,1.9169587909947807,0.07340539950808059,False
antipsychotic drug dosage in schizophrenia or schizoaffective disorder,13.771338250790306,0.0759682040785315,False
Parental longevity (father's attained age),12.7866927592955,0.08117124417132211,False
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event),12.7866927592955,0.08117124417132211,False
Low density lipoprotein cholesterol levels,2.9948924315121497,0.0860863758575046,False
Verbal declarative memory,11.933333333333334,0.08634538068696146,False
Hypertriglyceridemia,11.933333333333334,0.08634538068696146,False
Extremely high intelligence,11.933333333333334,0.08634538068696146,False
Spatial memory,11.933333333333334,0.08634538068696146,False
Waist-to-hip ratio adjusted for BMI,1.9173805528570167,0.08871766263036027,False
Balding type 1,2.9456414160639515,0.08932094386860523,False
"Facial morphology (factor 15, philtrum width)",11.186643835616438,0.09149077199651498,False
Kawasaki disease,11.186643835616438,0.09149077199651498,False
Spontaneous preterm birth (preterm birth),11.186643835616438,0.09149077199651498,False
Cocaine dependence,10.527800161160355,0.09660757562432662,False
Alzheimer's disease in APOE e4- carriers,9.942161339421613,0.10169594823702377,False
Eosinophilic esophagitis,9.942161339421613,0.10169594823702377,False
Parental lifespan,9.942161339421613,0.10169594823702377,False
Interferon gamma levels,9.418168709444846,0.10675604566460895,False
Interleukin-2 receptor antagonist levels,9.418168709444846,0.10675604566460895,False
Acne (severe),8.946575342465753,0.11178802286988594,False
Sleep duration,3.5348583877995643,0.11604943502969883,False
Mean corpuscular hemoglobin concentration,3.5348583877995643,0.11604943502969883,False
Post-traumatic stress disorder,8.51989562948467,0.11679203400691954,False
Immature fraction of reticulocytes,3.500269687162891,0.11788975488888671,False
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),8.13200498132005,0.12176823238593423,False
Sensorimotor dexterity,8.13200498132005,0.12176823238593423,False
Height,1.437363426359493,0.12454301520386682,False
Urate levels,2.5168231611893583,0.12555756849327024,False
Headache,7.453196347031963,0.13163779995234767,False
Alopecia areata,7.453196347031963,0.13163779995234767,False
Age at first sexual intercourse,7.154520547945205,0.1365314716283961,False
Feeling hurt,7.154520547945205,0.1365314716283961,False
Lipid metabolism phenotypes,7.154520547945205,0.1365314716283961,False
Interleukin-12p70 levels,7.154520547945205,0.1365314716283961,False
Body mass index,1.517366255144033,0.13904259910599354,False
Coronary artery disease,2.0665584415584415,0.1402922564546396,False
Hypertension,3.0781101614434947,0.14437447297742936,False
Obesity (extreme),6.623541349568747,0.146237340881461,False
Asthma (age of onset),6.623541349568747,0.146237340881461,False
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),6.623541349568747,0.146237340881461,False
Hand grip strength,3.025910364145658,0.14825592379731226,False
Lung function (FVC),1.8503983302466414,0.14830560980701057,False
Venous thromboembolism,3.000462962962963,0.1502047663106842,False
Response to paliperidone in schizophrenia (positive Marder score),6.386497064579256,0.15104983606292807,False
IgG glycosylation,2.2802698544206415,0.15400089416088844,False
Sj√∂gren's syndrome,6.165800661313179,0.15583556868943096,False
Autism spectrum disorder,6.165800661313179,0.15583556868943096,False
Mumps,5.959817351598174,0.16059468554472017,False
Systolic blood pressure x smoking status (ever vs never) interaction (2df test),5.959817351598174,0.16059468554472017,False
Systemic lupus erythematosus,2.2324813075986785,0.16073383728224958,False
Mean arterial pressure,2.833552055993001,0.16398716491512358,False
Psoriasis vulgaris,5.767123287671233,0.1653273326567646,False
Creatine kinase levels,5.767123287671233,0.1653273326567646,False
Intelligence,2.186619718309859,0.16755654748561125,False
Waist-to-hip ratio adjusted for BMI in active individuals,5.586472602739726,0.17003365522004674,False
"Parental longevity (combined parental attained age, Martingale residuals)",5.586472602739726,0.17003365522004674,False
Autism spectrum disorder or schizophrenia,2.74618320610687,0.17196316996874095,False
Migraine - clinic-based,5.416770444167704,0.1747137976834301,False
Intelligence (MTAG),2.1339691693467895,0.17585593085257079,False
Medication use (agents acting on the renin-angiotensin system),2.624695863746959,0.18404543929241063,False
LDL cholesterol levels x long total sleep time interaction (2df test),4.964231354642314,0.18859857703407062,False
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction),4.964231354642314,0.18859857703407062,False
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test),4.8296927064050355,0.19317542780909658,False
"Allergic disease (asthma, hay fever or eczema)",2.531298904538341,0.19420816734082566,False
Pediatric autoimmune diseases,4.702235039653929,0.1977268089898032,False
Myocardial infarction,4.702235039653929,0.1977268089898032,False
Cognitive ability,4.702235039653929,0.1977268089898032,False
Fat-free mass,2.478352490421456,0.200341351614151,False
Dental caries,4.581313663505444,0.20225286038017037,False
Prostate cancer,2.461187214611872,0.20239109875766043,False
Albumin-globulin ratio,4.4664383561643834,0.20675372104403994,False
Triglyceride levels x short total sleep time interaction (2df test),4.4664383561643834,0.20675372104403994,False
Stroke,4.4664383561643834,0.20675372104403994,False
Eosinophil percentage of granulocytes,2.394814814814815,0.21061438821914796,False
Pneumonia,4.357166722352155,0.21122952924621163,False
Monocyte chemoattractant protein-1 levels,4.253098499673842,0.2156804225523827,False
LDL cholesterol levels x short total sleep time interaction (2df test),4.153870659445683,0.22010653776095315,False
Atopic dermatitis,4.153870659445683,0.22010653776095315,False
Mean arterial pressure x alcohol consumption interaction (2df test),4.059153175591532,0.22450801092966494,False
White blood cell count,1.508298755186722,0.22611943387882255,False
Ischemic stroke,3.9686453576864538,0.2288849773842988,False
Ulcerative colitis,2.243402777777778,0.2313118535443438,False
Systolic blood pressure,1.44515517649846,0.23217003569741748,False
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)",2.2016019086571235,0.23755057640551666,False
Ocular sarcoidosis,3.7991839113960943,0.23756592778773258,False
White matter microstructure (mode of anisotropy),3.7991839113960943,0.23756592778773258,False
LDL cholesterol levels in current drinkers,3.7991839113960943,0.23756592778773258,False
Total cholesterol levels,1.8126476982701578,0.23974356313354286,False
Eczema,2.1745791245791244,0.24171528101009843,False
Body fat distribution (arm fat ratio),3.6435560525580093,0.24615045695733162,False
PR interval,3.5704109589041098,0.2504068941778157,False
Trauma exposure,3.5001343002954606,0.2546396213624215,False
Systemic sclerosis,3.5001343002954606,0.2546396213624215,False
Body mass index in physically active individuals,3.4325605900948366,0.2588487688010943,False
Cancer,3.4325605900948366,0.2588487688010943,False
Chronic lymphocytic leukemia,3.367536831222538,0.26303446605829245,False
"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)",2.0252667922159446,0.26676131307221174,False
Educational attainment,3.3049213597158804,0.26719684199581095,False
Systolic blood pressure x alcohol consumption interaction (2df test),3.3049213597158804,0.26719684199581095,False
Intracranial aneurysm,3.244582814445828,0.2713360247759726,False
Diastolic blood pressure x alcohol consumption interaction (2df test),3.186399217221135,0.2754521418948768,False
Serum metabolite levels (CMS),3.130257149723624,0.27954532011486455,False
Cognitive ability (MTAG),3.130257149723624,0.27954532011486455,False
HDL cholesterol levels x short total sleep time interaction (2df test),3.0760510155880962,0.2836156855410726,False
Body mass index (joint analysis main effects and physical activity interaction),3.0760510155880962,0.2836156855410726,False
Cigarettes smoked per day (MTAG),3.0760510155880962,0.2836156855410726,False
Multiple sclerosis,1.642992098935074,0.28536241018004155,False
LDL cholesterol,1.915478312537136,0.2876475606015696,False
White matter microstructure (mean diusivities),3.0236823775249593,0.287663363572197,False
Glycated hemoglobin levels,3.0236823775249593,0.287663363572197,False
Reaction time,1.6277179694481085,0.28997614150432427,False
Nonatopic asthma,2.9730593607305935,0.2916884789587234,False
Waist circumference adjusted for BMI in non-smokers,2.9730593607305935,0.2916884789587234,False
Childhood ear infection,2.924096114978666,0.2956911557522863,False
White matter microstructure (axial diusivities),2.924096114978666,0.2956911557522863,False
Asthma (childhood onset),1.8648726851851851,0.2980739792305149,False
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2.8767123287671232,0.299671517326171,False
Male-pattern baldness,1.593132761063422,0.3007646320580114,False
Basal cell carcinoma,2.7863869863013697,0.30756578502354404,False
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2.7863869863013697,0.30756578502354404,False
Autoimmune traits,2.7863869863013697,0.30756578502354404,False
Inflammatory skin disease,2.743308746048472,0.3114799345867532,False
Number of sexual partners,2.743308746048472,0.3114799345867532,False
Risk-taking tendency (4-domain principal component model),2.743308746048472,0.3114799345867532,False
Vitiligo,2.701535907015359,0.3153722558184589,False
Birth weight,1.7801271420674405,0.3167842193057051,False
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),2.661010018401145,0.3192428687744998,False
Plateletcrit,1.7535403050108933,0.32299911354764343,False
Migraine,2.621676067687349,0.32309189290206064,False
Rosacea symptom severity,2.5834822314869963,0.3269194469598459,False
Waist circumference adjusted for BMI (adjusted for smoking behaviour),2.546379647749511,0.33072564907902,False
White blood cell count (basophil),2.546379647749511,0.33072564907902,False
Asthma (adult onset),2.546379647749511,0.33072564907902,False
Crohn's disease,1.719284188034188,0.3312648726093729,False
HDL cholesterol levels in current drinkers,2.4079970381340243,0.34573927841182683,False
Tuberculosis,2.3757077625570777,0.3494404704759906,False
Body fat distribution (leg fat ratio),2.3757077625570777,0.3494404704759906,False
Glomerular filtration rate (creatinine),2.3442682047584715,0.3531210060435711,False
General factor of neuroticism,2.3136452588507384,0.35678099881872255,False
Inflammatory bowel disease,1.6017688091679123,0.36200198314697446,False
High density lipoprotein cholesterol levels,1.5944940476190477,0.3640342678068894,False
Colonoscopy-negative controls vs population controls,2.2263698630136988,0.3676388483413692,False
White matter microstructure (radial diusivities),2.1987146964315913,0.371217794819574,False
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),2.1987146964315913,0.371217794819574,False
Resting heart rate,2.1717340461075842,0.3747767578885671,False
Body fat distribution (trunk fat ratio),2.1717340461075842,0.3747767578885671,False
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),2.1196999347684278,0.381835173442956,False
Parkinson's disease or first degree relation to individual with Parkinson's disease,2.1196999347684278,0.381835173442956,False
White matter microstructure (fractional anisotropy),2.046134467013069,0.39227565332493125,False
LDL cholesterol levels,1.9774733637747337,0.4025421421082477,False
Triglycerides,1.4615209471766848,0.4041421340332915,False
Adventurousness,1.87267483777938,0.419274058114108,False
Cardiovascular disease,1.4085419411506368,0.42181391598881374,False
"anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)",1.7783561643835617,0.4355435505242078,False
Parkinson's disease,1.7606130476061306,0.4387430738802881,False
Depression,1.7606130476061306,0.4387430738802881,False
Mosquito bite size,1.7606130476061306,0.4387430738802881,False
Medication use (thyroid preparations),1.743217835079237,0.44192470497583797,False
Diisocyanate-induced asthma,1.7094309799789251,0.4482346847365661,False
Night sleep phenotypes,1.615442092154421,0.46674536464987043,False
Neurociticism,1.615442092154421,0.46674536464987043,False
Lymphocyte percentage of white cells,1.615442092154421,0.46674536464987043,False
Hemoglobin concentration,1.6007651487103542,0.46977034303963516,False
Serum metabolite levels,1.4922297686197767,0.4933685080609381,False
Lung cancer,1.4673383901279293,0.49910427833162213,False
HDL cholesterol levels,1.4673383901279293,0.49910427833162213,False
Platelet count,1.2040489642184558,0.5005472467808024,False
Hay fever and/or eczema,1.45519874242084,0.5019480932294393,False
Blond vs. brown/black hair color,1.443256487359394,0.5047759794604226,False
Waist-hip ratio,1.0876394661999562,0.509021184324884,False
"Cholesterol, total",1.4199452054794521,0.51038431739747,False
Hypothyroidism,1.3863441780821917,0.5186795437553483,False
Well-being spectrum (multivariate analysis),1.3754911330572368,0.5214136892739094,False
Waist circumference,1.2755494234749187,0.5479262241148832,False
FEV1,1.2663405088062623,0.5504964038533698,False
Neutrophil percentage of granulocytes,1.2663405088062623,0.5504964038533698,False
Triglyceride levels,1.2307838660578387,0.5606337590307743,False
Depressive symptoms,1.2307838660578387,0.5606337590307743,False
3-hydroxypropylmercapturic acid levels in smokers,1.2222012281530468,0.563132652416878,False
Diastolic blood pressure,1.0289878807730102,0.5633255640866859,False
Lymphocyte counts,1.1810045662100457,0.5754183431483235,False
Heel bone mineral density,0.9795668498666812,0.5805635569297097,False
Weight,1.149973314356876,0.5850009511556624,False
Rheumatoid arthritis,1.149973314356876,0.5850009511556624,False
Granulocyte percentage of myeloid white cells,1.149973314356876,0.5850009511556624,False
Platelet distribution width,1.1133798569828552,0.5966796445706086,False
Atrial fibrillation,1.0925080331473025,0.6035306040215628,False
Pulse pressure,0.9664336383263082,0.6044352244837448,False
Monocyte count,1.072395184723952,0.6102667365796819,False
Monocyte percentage of white cells,1.059388073168731,0.6146946377983842,False
General risk tolerance (MTAG),1.059388073168731,0.6146946377983842,False
Morning person,1.046688822242036,0.6190729042061425,False
Hip circumference adjusted for BMI,1.0281936922586812,0.6255484375339062,False
Colorectal cancer,1.0221711932852957,0.6276827220279213,False
Schizophrenia,0.9042542928805711,0.6476188476328606,False
Cognitive performance (MTAG),0.8992346938775511,0.6546386115617779,False
Morningness,0.9446194417991356,0.6563323499278513,False
Estimated glomerular filtration rate,0.8672687465790914,0.6735199325792558,False
Insomnia,0.9006150405367627,0.6735898106828029,False
Educational attainment (years of education),0.8131049392981873,0.7240139708020263,False
Breast cancer,0.7815515961395694,0.72639454526985,False
HDL cholesterol,0.7722903148281663,0.7283048135935415,False
Mean platelet volume,0.7424426333737935,0.7419904351090454,False
Cognitive performance,0.7424426333737935,0.7419904351090454,False
Type 2 diabetes,0.7404862579281184,0.752690635754637,False
Smoking initiation (ever regular vs never regular),0.7031232876712329,0.7605659535335718,False
Blood protein levels,0.7818882242484078,0.7834531388390796,False
Menarche (age at onset),0.5570194572899398,0.8344408900418514,False
Appendicular lean mass,0.5570194572899398,0.8344408900418514,False
Lung function (FEV1/FVC),0.6119913928012519,0.8366787735189117,False
Hair color,0.5445738915205053,0.841006616402991,False
Neuroticism,0.5196510110893673,0.8542233312093663,False
General cognitive ability,0.5312820512820513,0.8877147628514784,False
Highest math class taken (MTAG),0.5129794973544973,0.8986842937007326,False
C-reactive protein levels,0.43431506849315066,0.8994517664637756,False
Smoking initiation (ever regular vs never regular) (MTAG),0.3982679892930247,0.9180002751856658,False
Self-reported math ability (MTAG),0.37003901322929805,0.9319814684900837,False
Core binding factor acute myeloid leukemia,0.4270268391044361,0.9449482033185826,False
Metabolite levels,0.3288354596009159,0.9819111594047064,False
Adolescent idiopathic scoliosis,0.21605198454513522,0.9893455638245214,False
Educational attainment (MTAG),0.20378374783880834,0.9918206355378242,False
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome,0.0,1.0,False
Intake of sweets,0.0,1.0,False
Feeling nervous,0.0,1.0,False
Perceived intensity of neohesperidin dihydrochalcone,0.0,1.0,False
Osteoarthritis of the hip or knee,0.0,1.0,False
Eye morphology,0.0,1.0,False
Lactate dehydrogenase levels,0.0,1.0,False
Nose morphology,0.0,1.0,False
Feeling miserable,0.0,1.0,False
Clostridium difficile infection in multiple myeloma,0.0,1.0,False
Total body bone mineral density (age over 60),0.0,1.0,False
Total body bone mineral density (age 45-60),0.0,1.0,False
Osteoarthritis (self-reported),0.0,1.0,False
Irritable mood,0.0,1.0,False
Feeling worry,0.0,1.0,False
DNA methylation variation (age effect),0.0,1.0,False
Total body bone mineral density,0.0,1.0,False
Cerebrospinal fluid biomarker levels,0.0,1.0,False
Nonsyndromic cleft palate,0.0,1.0,False
Worry too long after an embarrassing experience,0.0,1.0,False
Atypical femoral fracture in phosphonate treatment,0.0,1.0,False
Feeling fed-up,0.0,1.0,False
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome),0.0,1.0,False
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,0.0,1.0,False
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),0.0,1.0,False
Alcohol consumption (drinks per week),0.0,1.0,False
Alcohol consumption (drinkers vs non-drinkers),0.0,1.0,False
Medication use (calcium channel blockers),0.0,1.0,False
Body mass index (adult),0.0,1.0,False
Medication use (beta blocking agents),0.0,1.0,False
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL),0.0,1.0,False
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes,0.0,1.0,False
Conotruncal heart defects (maternal effects),0.0,1.0,False
Congenital heart disease (maternal effect),0.0,1.0,False
Cutaneous squamous cell carcinoma,0.0,1.0,False
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,0.0,1.0,False
Urinary metabolite levels in chronic kidney disease,0.0,1.0,False
Alcohol consumption (drinks per week) (MTAG),0.0,1.0,False
Mood instability,0.0,1.0,False
Nicotine withdrawal symptom count,0.0,1.0,False
Bone ultrasound measurement (broadband ultrasound attenuation),0.0,1.0,False
Angiotensin-converting enzyme inhibitor intolerance,0.0,1.0,False
Feeling tense,0.0,1.0,False
Social science traits (pleiotropy) (HIPO component 1),0.0,1.0,False
Surgical necrotising enterocolitis in extremely premature birth,0.0,1.0,False
Glycemic traits (pleiotropy),0.0,1.0,False
Nevus count or cutaneous melanoma,0.0,1.0,False
Idiopathic intracranial hypertension,0.0,1.0,False
DHEAS levels,0.0,1.0,False
Sphingomyelin levels,0.0,1.0,False
Adverse response to drug,0.0,1.0,False
Smoking behaviour (cigarette pack-years),0.0,1.0,False
Erosive tooth wear (severe vs none or mild),0.0,1.0,False
Alzheimer's disease progression score,0.0,1.0,False
Maximum habitual alcohol consumption,0.0,1.0,False
17-hydroxyprogesterone (17-OHP) levels,0.0,1.0,False
Colorectal cancer or advanced adenoma,0.0,1.0,False
Broad depression or schizophrenia,0.0,1.0,False
Diffusing capacity of carbon monoxide,0.0,1.0,False
Serum metabolite ratios in chronic kidney disease,0.0,1.0,False
Coronary artery disease in type 1 diabetes,0.0,1.0,False
Serum metabolite concentrations in chronic kidney disease,0.0,1.0,False
Phosphatidylcholine levels,0.0,1.0,False
Medication use (diuretics),0.0,1.0,False
Erosive tooth wear (severe vs non-severe),0.0,1.0,False
Nevus count,0.0,1.0,False
Nicotine dependence symptom count,0.0,1.0,False
Lipid traits (pleiotropy) (HIPO component 1),0.0,1.0,False
Recurrent major depressive disorder,0.0,1.0,False
Lobe attachment (rater-scored or self-reported),0.0,1.0,False
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,0.0,1.0,False
Asthma exacerbations in inhaled corticosteroid treatment,0.0,1.0,False
Urolithiasis,0.0,1.0,False
Resting-state electroencephalogram vigilance,0.0,1.0,False
Bisphosphonate-associated atypical femoral fracture,0.0,1.0,False
Asthma or allergic disease (pleiotropy),0.0,1.0,False
Suicide attempts in bipolar disorder or schizophrenia,0.0,1.0,False
Leukocyte telomere length,0.0,1.0,False
Intake of total sugars,0.0,1.0,False
Late-onset Alzheimer's disease,0.0,1.0,False
Lysophosphatidylcholine levels,0.0,1.0,False
Gait speed in old age,0.0,1.0,False
Cardiac troponin-I levels,0.0,1.0,False
Triacylglyceride levels,0.0,1.0,False
Suicide attempts in schizophrenia,0.0,1.0,False
Serum bilirubin levels in metabolic syndrome,0.0,1.0,False
Rapid automised naming of digits,0.0,1.0,False
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes,0.0,1.0,False
Spherical equivalent (joint analysis main effects and education interaction),0.0,1.0,False
Alcohol consumption (heavy vs. light/non-drinkers),0.0,1.0,False
Bone mineral density (Ward's triangle area),0.0,1.0,False
Smoking behaviour (cigarettes smoked per day),0.0,1.0,False
QRS complex (12-leadsum),0.0,1.0,False
Velopharyngeal dysfunction,0.0,1.0,False
Daytime sleep phenotypes,0.0,1.0,False
Myeloid white cell count,0.0,1.0,False
Cognitive empathy,0.0,1.0,False
Pediatric bone mineral density (femoral neck),0.0,1.0,False
Methadone dose in opioid dependence,0.0,1.0,False
Type 2 diabetes (age of onset),0.0,1.0,False
Sense of smell,0.0,1.0,False
Sum basophil neutrophil counts,0.0,1.0,False
Hepcidin/transferrin saturation ratio,0.0,1.0,False
Hepcidin/ferritin ratio,0.0,1.0,False
Clopidogrel active metabolite levels,0.0,1.0,False
Pelvic organ prolapse,0.0,1.0,False
Childhood body mass index,0.0,1.0,False
Gastroesophageal reflux disease,0.0,1.0,False
Gestational age at birth in labor-initiated deliveries (child effect),0.0,1.0,False
Highest math class taken,0.0,1.0,False
Gestational age at birth (child effect),0.0,1.0,False
Pelvic organ prolapse (moderate/severe),0.0,1.0,False
Parental longevity (mother's age at death),0.0,1.0,False
Cannabis dependence symptom count,0.0,1.0,False
Macular thickness,0.0,1.0,False
LDL peak particle diameter (total fat intake interaction),0.0,1.0,False
Health literacy,0.0,1.0,False
Triptolide cytotoxicity,0.0,1.0,False
Strabismus,0.0,1.0,False
Cleft palate,0.0,1.0,False
Granulocyte count,0.0,1.0,False
Prostate-specific antigen levels (conditioned on lead SNPs),0.0,1.0,False
Gut microbiota (functional units),0.0,1.0,False
Response to paliperidone in schizophrenia (PANSS score),0.0,1.0,False
Response to paliperidone in schizophrenia (Multivariate),0.0,1.0,False
Response to paliperidone in schizophrenia (CGI-S score),0.0,1.0,False
Body fat mass,0.0,1.0,False
Cleft lip with or without cleft palate,0.0,1.0,False
Aggressiveness in attention deficit hyperactivity disorder,0.0,1.0,False
Celiac disease and Rheumatoid arthritis,0.0,1.0,False
Metabolite levels (small molecules and protein measures),0.0,1.0,False
Metabolite levels (lipoprotein measures),0.0,1.0,False
Positive affect,0.0,1.0,False
Life satisfaction,0.0,1.0,False
Asthma (moderate or severe),0.0,1.0,False
Bipolar disorder or attention deficit hyperactivity disorder,0.0,1.0,False
Bone mineral density (total hip),0.0,1.0,False
C-reactive protein levels or LDL-cholesterol levels (pleiotropy),0.0,1.0,False
C-reactive protein levels or total cholesterol levels (pleiotropy),0.0,1.0,False
C-reactive protein levels or HDL-cholesterol levels (pleiotropy),0.0,1.0,False
C-reactive protein levels or triglyceride levels (pleiotropy),0.0,1.0,False
Cancer (pleiotropy),0.0,1.0,False
Autoimmune traits (pleiotropy),0.0,1.0,False
Oropharynx cancer,0.0,1.0,False
QRS interval (sulfonylurea treatment interaction),0.0,1.0,False
Parental extreme longevity (95 years and older),0.0,1.0,False
Arterial stiffness index,0.0,1.0,False
Systemic juvenile idiopathic arthritis,0.0,1.0,False
Posterior cortical atrophy and Alzheimer's disease,0.0,1.0,False
Macrophage inflammatory protein 1a levels,0.0,1.0,False
Macrophage inflammatory protein 1b levels,0.0,1.0,False
Platelet-derived growth factor BB levels,0.0,1.0,False
RANTES levels,0.0,1.0,False
Stem cell growth factor beta levels,0.0,1.0,False
Adult asthma,0.0,1.0,False
Medication use (antithrombotic agents),0.0,1.0,False
Stem cell factor levels,0.0,1.0,False
Medication use (drugs used in diabetes),0.0,1.0,False
Itch intensity from mosquito bite adjusted by bite size,0.0,1.0,False
Perceived unattractiveness to mosquitoes,0.0,1.0,False
Survival in pancreatic cancer,0.0,1.0,False
Iris color (b* coordinate),0.0,1.0,False
Iris heterochromicity,0.0,1.0,False
Iris color (L* coordinate),0.0,1.0,False
Iris color (a* coordinate),0.0,1.0,False
Acute graft versus host disease in bone marrow transplantation (recipient effect),0.0,1.0,False
Alcoholic chronic pancreatitis,0.0,1.0,False
TB-LM or TBLH-BMD (pleiotropy),0.0,1.0,False
"Medication use (adrenergics, inhalants)",0.0,1.0,False
Blood pressure traits (multi-trait analysis),0.0,1.0,False
Alanine transaminase levels,0.0,1.0,False
Itch intensity from mosquito bite,0.0,1.0,False
Medication use (antiglaucoma preparations and miotics),0.0,1.0,False
Barrett's esophagus  or Esophageal adenocarcinoma,0.0,1.0,False
Medication use (glucocorticoids),0.0,1.0,False
Medication use (HMG CoA reductase inhibitors),0.0,1.0,False
Monokine induced by gamma interferon levels,0.0,1.0,False
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes,0.0,1.0,False
Smoking cessation (MTAG),0.0,1.0,False
Interleukin-16 levels,0.0,1.0,False
beta-nerve growth factor levels,0.0,1.0,False
Self-reported math ability,0.0,1.0,False
CTACK levels,0.0,1.0,False
Eotaxin levels,0.0,1.0,False
Growth-regulated protein alpha levels,0.0,1.0,False
Granulocyte-colony stimulating factor levels,0.0,1.0,False
Fibroblast growth factor basic levels,0.0,1.0,False
Interleukin-1-receptor antagonist levels,0.0,1.0,False
Hepatocyte growth factor levels,0.0,1.0,False
Heart rate in heart failure with reduced ejection fraction,0.0,1.0,False
Interleukin-2 levels,0.0,1.0,False
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event),0.0,1.0,False
Interleukin-4 levels,0.0,1.0,False
Interleukin-8 levels,0.0,1.0,False
Interleukin-9 levels,0.0,1.0,False
Interleukin-6 levels,0.0,1.0,False
Interleukin-7 levels,0.0,1.0,False
Interleukin-10 levels,0.0,1.0,False
Interleukin-5 levels,0.0,1.0,False
Interleukin-17 levels,0.0,1.0,False
Interleukin-13 levels,0.0,1.0,False
Macrophage Migration Inhibitory Factor levels,0.0,1.0,False
Interferon gamma-induced protein 10 levels,0.0,1.0,False
Breast cancer and/or colorectal cancer,0.0,1.0,False
Depression in smokers,0.0,1.0,False
Basophil percentage of white cells,0.0,1.0,False
Lumbar spine bone mineral density (integral),0.0,1.0,False
Macrophage colony stimulating factor levels,0.0,1.0,False
Low susceptibility to hepatitis C infection,0.0,1.0,False
High IL-1beta levels in gingival crevicular fluid,0.0,1.0,False
Huntington's disease progression,0.0,1.0,False
Mental composite score,0.0,1.0,False
Diverticular disease,0.0,1.0,False
Resistant hypertension,0.0,1.0,False
Mosaic loss of chromosome Y (Y chromosome dosage),0.0,1.0,False
Brown vs. black hair color,0.0,1.0,False
Bitter beverage consumption,0.0,1.0,False
Voxel-wise structural brain imaging measurements in Alzheimer‚Äôs disease,0.0,1.0,False
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis),0.0,1.0,False
Alcohol use disorder (consumption score),0.0,1.0,False
Plasma anti-thyroglobulin levels,0.0,1.0,False
"Number of decayed, missing and filled tooth surfaces or use of dentures",0.0,1.0,False
Dentures,0.0,1.0,False
Childhood obesity,0.0,1.0,False
Vertical cup-disc ratio (adjusted for vertical disc diameter),0.0,1.0,False
Alcohol use disorder (total score),0.0,1.0,False
Physiological traits,0.0,1.0,False
Birth weight (MTAG),0.0,1.0,False
Birth length (MTAG),0.0,1.0,False
Infant head circumference (MTAG),0.0,1.0,False
Lung function (low FEV1 vs high FEV1),0.0,1.0,False
Lung function in never smokers (low FEV1 vs high FEV1),0.0,1.0,False
Smoking status (heavy vs never),0.0,1.0,False
Cognitive impairment test score,0.0,1.0,False
Triglyceride levels x long total sleep time interaction (2df test),0.0,1.0,False
Corneal endothelial cell density,0.0,1.0,False
Rapid automised naming of letters,0.0,1.0,False
Brainstem volume,0.0,1.0,False
Plasma free amino acid levels (adjusted for twenty other PFAAs),0.0,1.0,False
Lifetime smoking index,0.0,1.0,False
Corneal endothelial cell size variation coefficient,0.0,1.0,False
Age-related cognitive decline (memory) (slope of z-scores),0.0,1.0,False
Pancreatic ductal adenocarcinoma,0.0,1.0,False
Worry,0.0,1.0,False
Fractures,0.0,1.0,False
Spherical equivalent or myopia (age of diagnosis),0.0,1.0,False
Optic disc size,0.0,1.0,False
Skin reflectance (Melanin index),0.0,1.0,False
"Obstructive sleep apnea trait (apnea hypopnea index, change over time)",0.0,1.0,False
Prostate cancer (advanced),0.0,1.0,False
Anthropometric traits (multi-trait analysis),0.0,1.0,False
Household income (MTAG),0.0,1.0,False
Hair morphology traits,0.0,1.0,False
Household income,0.0,1.0,False
"Dental caries (decayed, missing and filled teeth)",0.0,1.0,False
Dental caries (decayed and filled deciduous teeth),0.0,1.0,False
Erectile dysfunction,0.0,1.0,False
Cytokine network levels (multivariate analysis),0.0,1.0,False
Smoking status (ever vs never smokers),0.0,1.0,False
Vertical cup-disc ratio (multi-trait analysis),0.0,1.0,False
Sleep duration (short sleep),0.0,1.0,False
Moderate-to-late spontaneous preterm birth,0.0,1.0,False
Spontaneous preterm birth with premature rupture of membranes,0.0,1.0,False
Spontaneous preterm birth without premature rupture of membranes,0.0,1.0,False
Serum platinum levels after completion of cisplatin chemotherapy,0.0,1.0,False
Aspartate aminotransferase levels in excessive alcohol consumption,0.0,1.0,False
Gamma glutamyl transferase levels in low alcohol consumption,0.0,1.0,False
Gamma glutamyl transferase levels in excessive alcohol consumption,0.0,1.0,False
Alanine aminotransferase levels in excessive alcohol consumption,0.0,1.0,False
Alanine aminotransferase levels in low alcohol consumption,0.0,1.0,False
Early spontaneous preterm birth,0.0,1.0,False
Red vs. brown/black hair color,0.0,1.0,False
Age at loss of ambulation in Duchenne muscular dystrophy,0.0,1.0,False
Retinal detachment or retinal break,0.0,1.0,False
Tea consumption,0.0,1.0,False
Non-alcoholic fatty liver disease activity score,0.0,1.0,False
Weight gain in amisulpride-treated first-episode psychosis,0.0,1.0,False
Peak expiratory flow,0.0,1.0,False
Major depressive disorder in trauma-unexposed individuals,0.0,1.0,False
BRCA1/2-negative high-risk breast cancer,0.0,1.0,False
Peginterferon alfa-2a treatment response in chronic hepatitis B infection,0.0,1.0,False
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event),0.0,1.0,False
Obese vs. thin,0.0,1.0,False
Nasal polyps,0.0,1.0,False
Emphysema annual change measurement in smokers (percent low attenuation area),0.0,1.0,False
Major depressive disorder in trauma exposed individuals,0.0,1.0,False
Trauma exposure in major depressive disorder,0.0,1.0,False
Trauma exposure in major depressive disorder-negative individuals,0.0,1.0,False
Insomnia symptoms (never/rarely vs. usually),0.0,1.0,False
Maximum cranial length,0.0,1.0,False
Serum folate levels,0.0,1.0,False
Urinary calcium excretion,0.0,1.0,False
Insulin-related traits (multivariate analysis),0.0,1.0,False
Emphysema annual change measurement in smokers (adjusted lung density),0.0,1.0,False
Reading ability (multivariate),0.0,1.0,False
Calcific aortic valve stenosis,0.0,1.0,False
Help-seeking from a GP,0.0,1.0,False
Phoneme awareness,0.0,1.0,False
Simvastatin-induced myopathy,0.0,1.0,False
Word spelling,0.0,1.0,False
Mitochondrial DNA copy number,0.0,1.0,False
Factor VII activity,0.0,1.0,False
Multisite chronic pain,0.0,1.0,False
Maximum cranial width,0.0,1.0,False
High myopia,0.0,1.0,False
Insomnia symptoms (never/rarely vs. sometimes/usually),0.0,1.0,False
Age-related cognitive decline (language) (slope of z-scores),0.0,1.0,False
Blood protein levels in cardiovascular risk,0.0,1.0,False
Total body bone mineral density (MTAG),0.0,1.0,False
Heel bone mineral density (MTAG),0.0,1.0,False
Neurological blood protein biomarker levels,0.0,1.0,False
Cataracts (operation),0.0,1.0,False
Plasma free amino acid levels,0.0,1.0,False
LDL cholesterol x physical activity interaction (2df test),0.0,1.0,False
Triglycerides x physical activity interaction (2df test),0.0,1.0,False
HDL cholesterol x physical activity interaction (2df test),0.0,1.0,False
Snoring,0.0,1.0,False
Hospital contact for infections,0.0,1.0,False
Circulating leptin levels in high cardiovascular risk,0.0,1.0,False
Urinary metabolite modules (eigenmetabolites) in chronic kidney disease,0.0,1.0,False
Liver fibrosis in non-alcoholic fatty acid liver disease,0.0,1.0,False
Glaucoma (multi-trait analysis),0.0,1.0,False
Bitter non-alcoholic beverage consumption,0.0,1.0,False
Hallux valgus,0.0,1.0,False
HDL cholesterol levels x long total sleep time interaction (2df test),0.0,1.0,False
Post-traumatic stress disorder (re-experiencing symptoms),0.0,1.0,False
B-cell acute lymphoblastic leukaemia,0.0,1.0,False
Alanine aminotransferase levels in non-alcoholic fatty liver disease,0.0,1.0,False
Proliferative diabetic retinopathy (vs NPDR and no DR),0.0,1.0,False
Proliferative diabetic retinopathy (vs no DR),0.0,1.0,False
Aspartate aminotransferase levels in non-alcoholic fatty liver disease,0.0,1.0,False
Gastrointestinal infection,0.0,1.0,False
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies),0.0,1.0,False
Aspartate aminotransferase levels in low alcohol consumption,0.0,1.0,False
Automobile speeding propensity,0.0,1.0,False
Varicose veins,0.0,1.0,False
Low tan response,0.0,1.0,False
Uterine fibroids (multi-trait analysis),0.0,1.0,False
Plasma factor VII activating protease levels,0.0,1.0,False
Response to antidepressants (symptom improvement),0.0,1.0,False
Response to antidepressants (symptom remission),0.0,1.0,False
Lateral orbital frontal cortex volume,0.0,1.0,False
Paracentral lobule volume,0.0,1.0,False
Eudaimonic well-being,0.0,1.0,False
Estimated glomerular filtration rate in diabetes,0.0,1.0,False
Estimated glomerular filtration rate in non-diabetics,0.0,1.0,False
Lateral ventricle volume,0.0,1.0,False
Childhood steroid-sensitive nephrotic syndrome,0.0,1.0,False
Pallidum volume,0.0,1.0,False
Endometrial cancer (endometrioid histology),0.0,1.0,False
Familial lung cancer,0.0,1.0,False
Thalamus volume,0.0,1.0,False
Familial lung adenocarcinoma,0.0,1.0,False
Putamen volume,0.0,1.0,False
Carpal tunnel syndrome,0.0,1.0,False
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),0.0,1.0,False
HDL cholesterol and triglyceride levels,0.0,1.0,False
Total intracranial volume,0.0,1.0,False
Ankle injury,0.0,1.0,False
Urinary albumin excretion (no hypertensive medication),0.0,1.0,False
Self-reported risk-taking behaviour,0.0,1.0,False
Seasonality and depression,0.0,1.0,False
Experiencing mood swings,0.0,1.0,False
Glycine levels,0.0,1.0,False
Feeling guilty,0.0,1.0,False
Antipsychotic drug-induced QTc interval change in schizophrenia,0.0,1.0,False
Joint damage in rheumatoid arthritis,0.0,1.0,False
Systemising,0.0,1.0,False
Sodium levels,0.0,1.0,False
Familial squamous cell lung carcinoma,0.0,1.0,False
Parental longevity (father's age at death),0.0,1.0,False
Total triglycerides levels,0.0,1.0,False
Cardiometabolic and hematological traits,0.0,1.0,False
High altitude adaptation,0.0,1.0,False
Common carotid intima-media thickness in HIV negative individuals,0.0,1.0,False
Age of smoking initiation (MTAG),0.0,1.0,False
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1),0.0,1.0,False
Disease progression in age-related macular degeneration,0.0,1.0,False
Initial alcohol sensitivity,0.0,1.0,False
Disease progression in age-related macular degeneration (adjusted for baseline),0.0,1.0,False
Epstein-Barr virus copy number in lymphoblastoid cell lines,0.0,1.0,False
Response to cognitive-behavioural therapy in anxiety disorder,0.0,1.0,False
Non-word reading,0.0,1.0,False
"Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",0.0,1.0,False
Circulating fibroblast growth factor 23 levels,0.0,1.0,False
Coenzyme Q10 levels,0.0,1.0,False
Cuneus cortex volume,0.0,1.0,False
Inferior parietal cortex volume,0.0,1.0,False
Lingual gyrus volume,0.0,1.0,False
Medial orbital frontal cortex volume,0.0,1.0,False
Plasma parathyroid hormone levels,0.0,1.0,False
Nicotine dependence and major depression (severity of comorbidity),0.0,1.0,False
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze),0.0,1.0,False
Lateral ventricle temporal horn volume,0.0,1.0,False
Pulse pressure x alcohol consumption interaction (2df test),0.0,1.0,False
Neonatal cytokine/chemokine levels (fetal genetic effect),0.0,1.0,False
Whole brain grey matter density,0.0,1.0,False
Cerebrospinal AB1-42 levels in normal cognition,0.0,1.0,False
Logical memory (delayed recall) in normal cognition,0.0,1.0,False
Blood urea nitrogen levels,0.0,1.0,False
Potassium levels,0.0,1.0,False
Heart rate response to exercise,0.0,1.0,False
Serum uric acid levels in response to allopurinol in gout,0.0,1.0,False
Alcohol use disorder,0.0,1.0,False
Working memory,0.0,1.0,False
Cerebrospinal fluid sTREM-2 levels,0.0,1.0,False
Cognitive performance (processing speed),0.0,1.0,False
Asthma (time to onset),0.0,1.0,False
Breast cancer specific mortality in estrogen receptor positive breast cancer,0.0,1.0,False
Urinary sodium excretion,0.0,1.0,False
Stress sensitivity (neuroticism score x major depressive disorder status interaction),0.0,1.0,False
Non-lobar intracerebral hemorrhage (MTAG),0.0,1.0,False
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),0.0,1.0,False
Parental longevity (mother's age at death or mother's attained age),0.0,1.0,False
Parental longevity (father's age at death or father's attained age),0.0,1.0,False
Breast cancer specific mortality in estrogen receptor negative breast cancer,0.0,1.0,False
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),0.0,1.0,False
Amblyopia,0.0,1.0,False
Body mass index variance,0.0,1.0,False
Waist circumference variance,0.0,1.0,False
Hip circumference variance,0.0,1.0,False
Bone mineral content,0.0,1.0,False
Brain region volumes,0.0,1.0,False
Cervical cancer (multi-trait analysis),0.0,1.0,False
Gynecologic disease (multivariate analysis),0.0,1.0,False
Breast cancer specific mortality in breast cancer,0.0,1.0,False
Atopic asthma,0.0,1.0,False
Depressed affect,0.0,1.0,False
Spherical equivalent,0.0,1.0,False
Myopia (age of diagnosis),0.0,1.0,False
Mucinous adenocarcinoma in colorectal cancer,0.0,1.0,False
Predicted visceral adipose tissue,0.0,1.0,False
Mental health study participation (completed survey),0.0,1.0,False
Left ventricle wall thickness,0.0,1.0,False
Regular attendance at a religious group,0.0,1.0,False
Chloride levels,0.0,1.0,False
Total bilirubin levels,0.0,1.0,False
Frontal fibrosing alopecia,0.0,1.0,False
Depression (broad),0.0,1.0,False
Offspring birth weight,0.0,1.0,False
Hemoglobin A1c levels,0.0,1.0,False
Blood sugar levels,0.0,1.0,False
Uveal melanoma,0.0,1.0,False
Sulfasalazine-induced agranulocytosis,0.0,1.0,False
Heart rate response to recovery post exercise,0.0,1.0,False
Upper eyelid sagging severity,0.0,1.0,False
Facial wrinkles,0.0,1.0,False
Depressive symptom improvement,0.0,1.0,False
Triglyceride levels in current drinkers,0.0,1.0,False
Benign prostatic hyperplasia and lower urinary tract symptoms,0.0,1.0,False
Response to hepatitis B vaccine,0.0,1.0,False
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded),0.0,1.0,False
End-stage kidney disease,0.0,1.0,False
3-month functional outcome in ischaemic stroke (modified Rankin score),0.0,1.0,False
Gut microbiota (alpha diversity),0.0,1.0,False
Gut microbiota relative abundance (bacterial taxa),0.0,1.0,False
Face memory,0.0,1.0,False
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy),0.0,1.0,False
California verbal learning test score,0.0,1.0,False
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy),0.0,1.0,False
Spatial processing,0.0,1.0,False
Waist-to-hip ratio adjusted for BMI (additive genetic model),0.0,1.0,False
Antisaccade task score,0.0,1.0,False
Obsessive-compulsive disorder,0.0,1.0,False
"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)",0.0,1.0,False
Loneliness (MTAG),0.0,1.0,False
Facial morphology (factor 19),0.0,1.0,False
Sum neutrophil eosinophil counts,0.0,1.0,False
Liver enzyme levels (alanine transaminase),0.0,1.0,False
Liver enzyme levels (gamma-glutamyl transferase),0.0,1.0,False
Behcet's disease,0.0,1.0,False
Periodontal microbiota,0.0,1.0,False
Caffeine consumption,0.0,1.0,False
Breast Cancer in BRCA1 mutation carriers,0.0,1.0,False
Liver enzyme levels (alkaline phosphatase),0.0,1.0,False
Response to anti-TNF therapy in rheumatoid arthritis,0.0,1.0,False
Self-rated health,0.0,1.0,False
Breast size,0.0,1.0,False
Non-albumin protein levels,0.0,1.0,False
HIV-1 susceptibility,0.0,1.0,False
Biochemical measures,0.0,1.0,False
Suicide attempts in bipolar disorder,0.0,1.0,False
Progressive supranuclear palsy,0.0,1.0,False
Information processing speed,0.0,1.0,False
White blood cell types,0.0,1.0,False
Testosterone levels,0.0,1.0,False
Visceral adipose tissue/subcutaneous adipose tissue ratio,0.0,1.0,False
Visceral adipose tissue adjusted for BMI,0.0,1.0,False
Palmitoleic acid (16:1n-7) levels,0.0,1.0,False
Hippocampal volume,0.0,1.0,False
Preeclampsia,0.0,1.0,False
Cannabis use (initiation),0.0,1.0,False
Sex hormone-binding globulin levels,0.0,1.0,False
IgM levels,0.0,1.0,False
Venous thromboembolism (SNP x SNP interaction),0.0,1.0,False
QRS duration,0.0,1.0,False
Non-melanoma skin cancer,0.0,1.0,False
Sunburns,0.0,1.0,False
Amyotrophic lateral sclerosis (age of onset),0.0,1.0,False
Disc degeneration (lumbar),0.0,1.0,False
Response to amphetamines,0.0,1.0,False
Visceral fat,0.0,1.0,False
Erectile dysfunction and prostate cancer treatment,0.0,1.0,False
Pulmonary function (smoking interaction),0.0,1.0,False
N-glycan levels,0.0,1.0,False
Cerebrospinal fluid AB1-42 levels,0.0,1.0,False
Cerebrospinal P-tau181p levels,0.0,1.0,False
Cerebrospinal T-tau levels,0.0,1.0,False
Attention deficit hyperactivity disorder (time to onset),0.0,1.0,False
Educational attainment (college completion),0.0,1.0,False
Panic disorder,0.0,1.0,False
Anorexia nervosa,0.0,1.0,False
Vertical cup-disc ratio,0.0,1.0,False
Hyperactive-impulsive symptoms,0.0,1.0,False
Hepatitis B,0.0,1.0,False
Obesity-related traits,0.0,1.0,False
Liver enzyme levels,0.0,1.0,False
Common traits (Other),0.0,1.0,False
Brain structure,0.0,1.0,False
Sphingolipid levels,0.0,1.0,False
Multiple myeloma,0.0,1.0,False
Hair morphology,0.0,1.0,False
Follicular lymphoma,0.0,1.0,False
Celiac disease or Rheumatoid arthritis,0.0,1.0,False
Hirschsprung disease,0.0,1.0,False
Gout,0.0,1.0,False
Heart failure,0.0,1.0,False
Hip geometry,0.0,1.0,False
Polycystic ovary syndrome,0.0,1.0,False
Leprosy,0.0,1.0,False
Thyroid stimulating hormone levels,0.0,1.0,False
Tonometry,0.0,1.0,False
Quantitative traits,0.0,1.0,False
Alcohol consumption,0.0,1.0,False
Primary tooth development (time to first tooth eruption),0.0,1.0,False
Primary tooth development (number of teeth),0.0,1.0,False
Aortic root size,0.0,1.0,False
Testicular germ cell tumor,0.0,1.0,False
Subcutaneous adipose tissue,0.0,1.0,False
Capecitabine sensitivity,0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid),0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid),0.0,1.0,False
Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid),0.0,1.0,False
Glomerular filtration rate,0.0,1.0,False
Aspartate aminotransferase levels,0.0,1.0,False
Multiple myeloma (IgH translocation),0.0,1.0,False
Lung function (FEV1),0.0,1.0,False
HIV-1 viral setpoint,0.0,1.0,False
Hodgkin's lymphoma,0.0,1.0,False
Immune reponse to smallpox (secreted IL-2),0.0,1.0,False
Immune reponse to smallpox (secreted IL-1beta),0.0,1.0,False
Immune reponse to smallpox (secreted IFN-alpha),0.0,1.0,False
Gamma glutamyl transferase levels,0.0,1.0,False
Economic and political preferences,0.0,1.0,False
Peripheral artery disease,0.0,1.0,False
Metabolite levels (Pyroglutamine),0.0,1.0,False
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity),0.0,1.0,False
Mortality in heart failure,0.0,1.0,False
Cholesterol,0.0,1.0,False
Irritable bowel syndrome,0.0,1.0,False
Serum thyroid-stimulating hormone levels,0.0,1.0,False
Preschool internalizing problems,0.0,1.0,False
Mitochondrial DNA levels,0.0,1.0,False
Endometrial cancer,0.0,1.0,False
Lipid traits,0.0,1.0,False
Adverse response to lamotrigine and phenytoin,0.0,1.0,False
Post-traumatic stress disorder (asjusted for relatedness),0.0,1.0,False
Eating disorders,0.0,1.0,False
Bulimia nervosa,0.0,1.0,False
Chronic hepatitis B infection,0.0,1.0,False
Abdominal aortic aneurysm,0.0,1.0,False
vWF and FVIII levels,0.0,1.0,False
D-dimer levels,0.0,1.0,False
Pulmonary function decline,0.0,1.0,False
Metabolite levels (Dihydroxy docosatrienoic acid),0.0,1.0,False
Cognitive function,0.0,1.0,False
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)",0.0,1.0,False
Response to tocilizumab in rheumatoid arthritis,0.0,1.0,False
Femoral neck bone mineral density,0.0,1.0,False
Lumbar spine bone mineral density,0.0,1.0,False
Periodontitis (DPAL),0.0,1.0,False
Periodontitis (CDC/AAP),0.0,1.0,False
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy),0.0,1.0,False
Periodontitis (Mean PAL),0.0,1.0,False
Cervical cancer,0.0,1.0,False
Esophageal cancer,0.0,1.0,False
Alzheimer's disease (cognitive decline),0.0,1.0,False
Thyroid hormone levels,0.0,1.0,False
Primary sclerosing cholangitis,0.0,1.0,False
Urinary metabolites,0.0,1.0,False
Response to anti-depressant treatment in major depressive disorder,0.0,1.0,False
Phospholipid levels (plasma),0.0,1.0,False
Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy),0.0,1.0,False
Urinary metabolites (H-NMR features),0.0,1.0,False
Immune response to smallpox vaccine (IL-6),0.0,1.0,False
Dialysis-related mortality,0.0,1.0,False
IgA nephropathy,0.0,1.0,False
Homeostasis model assessment of insulin resistance (dietary factor interaction),0.0,1.0,False
Metabolite levels  (X-11787),0.0,1.0,False
Response to angiotensin II receptor blocker therapy,0.0,1.0,False
Amyotrophic lateral sclerosis (sporadic),0.0,1.0,False
Frontotemporal dementia,0.0,1.0,False
vWF levels,0.0,1.0,False
Factor VIII levels,0.0,1.0,False
Bipolar I disorder,0.0,1.0,False
Intraocular pressure,0.0,1.0,False
Word reading,0.0,1.0,False
Social communication problems,0.0,1.0,False
Vascular endothelial growth factor levels,0.0,1.0,False
Protein C levels,0.0,1.0,False
Non-alcoholic fatty liver disease histology (other),0.0,1.0,False
Neutrophil count,0.0,1.0,False
Nasopharyngeal carcinoma,0.0,1.0,False
Acute lymphoblastic leukemia (childhood),0.0,1.0,False
Fibrinogen,0.0,1.0,False
Menopause (age at onset),0.0,1.0,False
Skin pigmentation,0.0,1.0,False
Osteoarthritis,0.0,1.0,False
Hippocampal atrophy,0.0,1.0,False
Homeostasis model assessment of beta-cell function,0.0,1.0,False
Type 2 diabetes nephropathy,0.0,1.0,False
Telomere length,0.0,1.0,False
C-reactive protein,0.0,1.0,False
Inflammatory biomarkers,0.0,1.0,False
Bipolar disorder,0.0,1.0,False
Bone mineral density,0.0,1.0,False
Fasting blood glucose,0.0,1.0,False
Warfarin maintenance dose,0.0,1.0,False
Fasting plasma glucose,0.0,1.0,False
Heart rate,0.0,1.0,False
Coronary heart disease,0.0,1.0,False
Refractive error,0.0,1.0,False
Pancreatic cancer,0.0,1.0,False
Red blood cell traits,0.0,1.0,False
Metabolic syndrome,0.0,1.0,False
Renal cell carcinoma,0.0,1.0,False
HIV-1 control,0.0,1.0,False
Diabetic retinopathy,0.0,1.0,False
Response to antipsychotic treatment,0.0,1.0,False
Electrocardiographic traits,0.0,1.0,False
Non-small cell lung cancer,0.0,1.0,False
Attention deficit hyperactivity disorder,0.0,1.0,False
Adiponectin levels,0.0,1.0,False
Kidney stones,0.0,1.0,False
Platelet aggregation,0.0,1.0,False
Alcohol dependence,0.0,1.0,False
QT interval,0.0,1.0,False
Glaucoma,0.0,1.0,False
Idiopathic membranous nephropathy,0.0,1.0,False
Idiopathic dilated cardiomyopathy,0.0,1.0,False
Cardiac hypertrophy,0.0,1.0,False
Type 1 diabetes,0.0,1.0,False
Melanoma,0.0,1.0,False
Bone mineral density (spine),0.0,1.0,False
Uterine fibroids,0.0,1.0,False
Bone mineral density (hip),0.0,1.0,False
Prostate-specific antigen levels,0.0,1.0,False
Primary biliary cholangitis,0.0,1.0,False
Pulmonary function,0.0,1.0,False
Nicotine dependence,0.0,1.0,False
Magnesium levels,0.0,1.0,False
Sudden cardiac arrest,0.0,1.0,False
Glioma,0.0,1.0,False
Chronic obstructive pulmonary disease,0.0,1.0,False
Endometriosis,0.0,1.0,False
Corneal astigmatism,0.0,1.0,False
Bladder cancer,0.0,1.0,False
Amyotrophic lateral sclerosis,0.0,1.0,False
Chronic kidney disease,0.0,1.0,False
Obesity,0.0,1.0,False
Gallstone disease,0.0,1.0,False
Tanning,0.0,1.0,False
Caudate nucleus volume,0.0,1.0,False
Uric acid levels,0.0,1.0,False
Blood pressure,0.0,1.0,False
Response to hepatitis C treatment,0.0,1.0,False
Metabolic traits,0.0,1.0,False
Lipoprotein-associated phospholipase A2 activity and mass,0.0,1.0,False
Lung adenocarcinoma,0.0,1.0,False
Idiopathic pulmonary fibrosis,0.0,1.0,False
Alzheimer's disease (late onset),0.0,1.0,False
Calcium levels,0.0,1.0,False
Response to treatment for acute lymphoblastic leukemia,0.0,1.0,False
Moyamoya disease,0.0,1.0,False
Homocysteine levels,0.0,1.0,False
Gastric cancer,0.0,1.0,False
Clozapine-induced agranulocytosis,0.0,1.0,False
Response to antipsychotic treatment in schizophrenia (working memory),0.0,1.0,False
Airflow obstruction,0.0,1.0,False
Nodular sclerosis Hodgkin lymphoma,0.0,1.0,False
Bilirubin levels,0.0,1.0,False
Hematological and biochemical traits,0.0,1.0,False
Activated partial thromboplastin time,0.0,1.0,False
Graves' disease,0.0,1.0,False
DNA methylation (variation),0.0,1.0,False
Hematology traits,0.0,1.0,False
Vitamin D levels,0.0,1.0,False
Eye color,0.0,1.0,False
Prothrombin time,0.0,1.0,False
Coronary artery calcification,0.0,1.0,False
Metabolite levels (HVA),0.0,1.0,False
Metabolite levels (HVA/MHPG ratio),0.0,1.0,False
Obesity (early onset extreme),0.0,1.0,False
Hemoglobin,0.0,1.0,False
Hematocrit,0.0,1.0,False
Anthropometric traits,0.0,1.0,False
Celiac disease,0.0,1.0,False
Prostate cancer (SNP x SNP interaction),0.0,1.0,False
Metabolite levels (MHPG),0.0,1.0,False
Corneal structure,0.0,1.0,False
Nonalcoholic fatty liver disease,0.0,1.0,False
Hemostatic factors and hematological phenotypes,0.0,1.0,False
Urinary albumin excretion,0.0,1.0,False
Optic disc area,0.0,1.0,False
Axial length,0.0,1.0,False
Longevity,0.0,1.0,False
Select biomarker traits,0.0,1.0,False
Squamous cell carcinoma,0.0,1.0,False
Interstitial lung disease,0.0,1.0,False
Presence of antiphospholipid antibodies,0.0,1.0,False
Pit-and-Fissure caries,0.0,1.0,False
Tourette syndrome,0.0,1.0,False
Dupuytren's disease,0.0,1.0,False
Myopia (pathological),0.0,1.0,False
Response to statin therapy,0.0,1.0,False
Glaucoma (primary open-angle),0.0,1.0,False
Smooth-surface caries,0.0,1.0,False
Glioblastoma,0.0,1.0,False
Orofacial clefts,0.0,1.0,False
Smoking behavior,0.0,1.0,False
Ovarian cancer,0.0,1.0,False
Major depressive disorder,0.0,1.0,False
Coffee consumption,0.0,1.0,False
Iron status biomarkers,0.0,1.0,False
Age-related macular degeneration,0.0,1.0,False
Renal function-related traits (BUN),0.0,1.0,False
Malaria,0.0,1.0,False
Bipolar disorder and schizophrenia,0.0,1.0,False
Cardiovascular disease risk factors,0.0,1.0,False
Interleukin-18 levels,0.0,1.0,False
Central corneal thickness,0.0,1.0,False
Personality dimensions,0.0,1.0,False
Attention deficit hyperactivity disorder and conduct disorder,0.0,1.0,False
Ankylosing spondylitis,0.0,1.0,False
Pubertal anthropometrics,0.0,1.0,False
Allergic rhinitis,0.0,1.0,False
Knee osteoarthritis,0.0,1.0,False
Protein quantitative trait loci,0.0,1.0,False
Hypospadias,0.0,1.0,False
Hematological parameters,0.0,1.0,False
IgE levels,0.0,1.0,False
Essential tremor,0.0,1.0,False
End-stage coagulation,0.0,1.0,False
Age-related hearing impairment,0.0,1.0,False
Age-related hearing impairment (SNP x SNP interaction),0.0,1.0,False
Osteoarthritis (hip),0.0,1.0,False
Response to antipsychotic therapy (extrapyramidal side effects),0.0,1.0,False
Heart rate variability traits (SDNN),0.0,1.0,False
Heart rate variability traits (RMSSD),0.0,1.0,False
Plantar warts,0.0,1.0,False
Cold sores,0.0,1.0,False
Shingles,0.0,1.0,False
Body mass index (joint analysis main effects and smoking interaction),0.0,1.0,False
Neurocognitive impairment in HIV-1 infection (dichotomous),0.0,1.0,False
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular),0.0,1.0,False
Urinary tract infection frequency,0.0,1.0,False
BMI in smokers,0.0,1.0,False
Gestational age at birth (maternal effect),0.0,1.0,False
Measles,0.0,1.0,False
Myringotomy,0.0,1.0,False
Yeast infection,0.0,1.0,False
BMI (adjusted for smoking behaviour),0.0,1.0,False
Rheumatic fever,0.0,1.0,False
Craniofacial microsomia,0.0,1.0,False
Ease of getting up in the morning,0.0,1.0,False
Red blood cell density in sickle cell anemia,0.0,1.0,False
Scarlet fever,0.0,1.0,False
Neuroticism (MTAG),0.0,1.0,False
Strep throat,0.0,1.0,False
Subjective well-being,0.0,1.0,False
Lung cancer in never smokers,0.0,1.0,False
IgG N-glycosylation phenotypes (multivariate analysis),0.0,1.0,False
Borderline personality disorder,0.0,1.0,False
Subjective well-being (MTAG),0.0,1.0,False
Mononucleosis,0.0,1.0,False
Rubella,0.0,1.0,False
Lung cancer in ever smokers,0.0,1.0,False
Squamous cell lung carcinoma,0.0,1.0,False
Small cell lung carcinoma,0.0,1.0,False
Depressive symptoms (MTAG),0.0,1.0,False
Chickenpox,0.0,1.0,False
Hepatitis A,0.0,1.0,False
Number of common colds,0.0,1.0,False
Thrombosis,0.0,1.0,False
Gut microbiome composition (winter),0.0,1.0,False
Ischemic stroke (large artery atherosclerosis),0.0,1.0,False
Alzheimer disease and age of onset,0.0,1.0,False
Post bronchodilator FEV1 in COPD,0.0,1.0,False
Hip circumference,0.0,1.0,False
Advanced age-related macular degeneration,0.0,1.0,False
Trans fatty acid levels,0.0,1.0,False
Major depression and alcohol dependence,0.0,1.0,False
Obstructive sleep apnea trait (apnea hypopnea index),0.0,1.0,False
Carboplatin disposition in epthelial ovarian cancer,0.0,1.0,False
Paclitaxel disposition in epithelial ovarian cancer,0.0,1.0,False
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),0.0,1.0,False
Initial pursuit acceleration in psychotic disorders,0.0,1.0,False
Lipoprotein phospholipase A2 activity in cardiovascular disease,0.0,1.0,False
Chronic sinus infection,0.0,1.0,False
Morning vs. evening chronotype,0.0,1.0,False
Cognitive decline rate in late mild cognitive impairment,0.0,1.0,False
Waist circumference adjusted for BMI in smokers,0.0,1.0,False
BMI in non-smokers,0.0,1.0,False
Caudate activity during reward,0.0,1.0,False
Lipoprotein (a) levels,0.0,1.0,False
Body mass index in physically inactive individuals,0.0,1.0,False
Primary biliary cirrhosis,0.0,1.0,False
Chronotype,0.0,1.0,False
Fear of minor pain,0.0,1.0,False
Colorectal adenoma (advanced),0.0,1.0,False
Post bronchodilator FEV1/FVC ratio,0.0,1.0,False
Takayasu arteritis,0.0,1.0,False
Body fat percentage,0.0,1.0,False
Cerebrospinal fluid t-tau:AB1-42 ratio,0.0,1.0,False
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging),0.0,1.0,False
Waist circumference adjusted for BMI in active individuals,0.0,1.0,False
Bacterial meningitis,0.0,1.0,False
Peripheral arterial disease (traffic-related air pollution interaction),0.0,1.0,False
Lean body mass,0.0,1.0,False
Glomerular filtration rate in chronic kidney disease,0.0,1.0,False
Diabetic kidney disease,0.0,1.0,False
Pediatric bone mineral content (radius),0.0,1.0,False
Colorectal or endometrial cancer,0.0,1.0,False
Nose size,0.0,1.0,False
Joint mobility (Beighton score),0.0,1.0,False
Lewy body disease,0.0,1.0,False
Gut microbiota (beta diversity),0.0,1.0,False
Monobrow,0.0,1.0,False
Photic sneeze reflex,0.0,1.0,False
Chin dimples,0.0,1.0,False
Allergy,0.0,1.0,False
Carotid plaque burden,0.0,1.0,False
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,0.0,1.0,False
Gut microbiota (bacterial taxa),0.0,1.0,False
Classic bladder exstrophy,0.0,1.0,False
Neurofibrillary tangles,0.0,1.0,False
Epilepsy and lamotrigine-induced maculopapular eruptions,0.0,1.0,False
Age-related diseases and mortality,0.0,1.0,False
Response to paliperidone in schizophrenia (negative Marder score),0.0,1.0,False
Cerebrospinal fluid clusterin levels,0.0,1.0,False
Suicide attempts in major depressive disorder,0.0,1.0,False
Influenza A (H1N1) infection,0.0,1.0,False
Severe influenza A (H1N1) infection,0.0,1.0,False
Neuritic plaque,0.0,1.0,False
Mild influenza (H1N1) infection,0.0,1.0,False
Coronary artery aneurysm in Kawasaki disease,0.0,1.0,False
Cough in response to angiotensin-converting enzyme inhibitor drugs,0.0,1.0,False
Microalbuminuria,0.0,1.0,False
Fibrinogen levels,0.0,1.0,False
Hemoglobin levels,0.0,1.0,False
Attention function in attention deficit hyperactive disorder,0.0,1.0,False
Cutaneous malignant melanoma,0.0,1.0,False
Response to zileuton treatment in asthma (FEV1 change interaction),0.0,1.0,False
3-hydroxy-1-methylpropylmercapturic acid levels in smokers,0.0,1.0,False
Dementia and core Alzheimer's disease neuropathologic changes,0.0,1.0,False
Facial morphology (factor 23),0.0,1.0,False
"Facial morphology (factor 14, intercanthal width)",0.0,1.0,False
"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)",0.0,1.0,False
"Facial morphology (factor 6, height of vermillion lower lip)",0.0,1.0,False
"Facial morphology (factor 4, facial height related to vertical position of gnathion)",0.0,1.0,False
"Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)",0.0,1.0,False
"Facial morphology (factor 21, depth of nasal alae)",0.0,1.0,False
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction),0.0,1.0,False
"Facial morphology (factor 2, vertical position of orbits relative to midface)",0.0,1.0,False
Facial morphology (factor 20),0.0,1.0,False
Facial morphology (factor 18),0.0,1.0,False
"Facial morphology (factor 17, height of vermillion upper lip)",0.0,1.0,False
Facial morphology (factor 16),0.0,1.0,False
Trunk fat mass,0.0,1.0,False
Smoking status,0.0,1.0,False
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction),0.0,1.0,False
Tenofovir clearance in HIV infection,0.0,1.0,False
Gut microbiome composition (summer),0.0,1.0,False
Percentage gas trapping,0.0,1.0,False
Emphysema imaging phenotypes,0.0,1.0,False
Urinary albumin-to-creatinine ratio,0.0,1.0,False
Venous thromboembolism adjusted for sickle cell variant rs77121243-T,0.0,1.0,False
Loneliness (linear analysis),0.0,1.0,False
Loneliness (multivariate analysis),0.0,1.0,False
Loneliness,0.0,1.0,False
Nonsyndromic cleft lip with cleft palate,0.0,1.0,False
Midgestational circulating levels of PBDEs (fetal genetic effect),0.0,1.0,False
Cerebral amyloid deposition (PET imaging),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (cognitive search score),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations),0.0,1.0,False
Exploratory eye movement dysfunction in schizophrenia (responsive search score),0.0,1.0,False
Glomerular filtration rate in non diabetics (creatinine),0.0,1.0,False
Eyebrow thickness,0.0,1.0,False
Idiopathic osteonecrosis of the femoral head,0.0,1.0,False
Left atrial antero-posterior diameter,0.0,1.0,False
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",0.0,1.0,False
Initial pursuit acceleration,0.0,1.0,False
Red blood cell fatty acid levels,0.0,1.0,False
Toenail selenium levels,0.0,1.0,False
Electroencephalogram traits,0.0,1.0,False
Glucose homeostasis traits,0.0,1.0,False
Blood pressure (smoking interaction),0.0,1.0,False
Epithelial ovarian cancer,0.0,1.0,False
Asymmetrical dimethylarginine levels,0.0,1.0,False
Phosphorus levels,0.0,1.0,False
Migraine without aura,0.0,1.0,False
Parasitemia in Tripanosoma cruzi seropositivity,0.0,1.0,False
QRS duration in Tripanosoma cruzi seropositivity,0.0,1.0,False
Fasting blood glucose (BMI interaction),0.0,1.0,False
Fasting blood insulin (BMI interaction),0.0,1.0,False
Response to platinum-based chemotherapy (cisplatin),0.0,1.0,False
Migraine with aura,0.0,1.0,False
Response to platinum-based chemotherapy (carboplatin),0.0,1.0,False
Symmetrical dimethylarginine levels,0.0,1.0,False
Barrett's esophagus,0.0,1.0,False
Response to abacavir-containing treatment in HIV-1 infection (virologic failure),0.0,1.0,False
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure),0.0,1.0,False
Mammographic density (dense area),0.0,1.0,False
Asthma and hay fever,0.0,1.0,False
Anger,0.0,1.0,False
Infant length,0.0,1.0,False
Esophageal adenocarcinoma,0.0,1.0,False
Behavioural disinhibition (generation interaction),0.0,1.0,False
Smoking initiation,0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid),0.0,1.0,False
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid),0.0,1.0,False
Smoking cessation,0.0,1.0,False
Age of smoking initiation,0.0,1.0,False
Carotid intima media thickness,0.0,1.0,False
White matter hyperintensity burden,0.0,1.0,False
Coronary artery disease or ischemic stroke,0.0,1.0,False
Generalized epilepsy,0.0,1.0,False
Lupus nephritis in systemic lupus erythematosus,0.0,1.0,False
IgA levels,0.0,1.0,False
Bipolar disorder (body mass index interaction),0.0,1.0,False
Psoriatic arthritis,0.0,1.0,False
Myopia,0.0,1.0,False
Serum alkaline phosphatase levels,0.0,1.0,False
Blood metabolite levels,0.0,1.0,False
Blood metabolite ratios,0.0,1.0,False
Methotrexate phramacokinetics (acute lymphoblastic leukemia),0.0,1.0,False
Free thyroxine concentration,0.0,1.0,False
Fractional exhaled nitric oxide (childhood),0.0,1.0,False
Airway responsiveness in chronic obstructive pulmonary disease,0.0,1.0,False
Cognitive decline (age-related),0.0,1.0,False
Alcohol dependence (age at onset),0.0,1.0,False
Coronary artery disease or large artery stroke,0.0,1.0,False
Serum uric acid levels,0.0,1.0,False
Corneal curvature,0.0,1.0,False
Large artery stroke,0.0,1.0,False
Creatinine levels,0.0,1.0,False
Facial morphology,0.0,1.0,False
Antineutrophil cytoplasmic antibody-associated vasculitis,0.0,1.0,False
Self-reported allergy,0.0,1.0,False
Ejection fraction in Tripanosoma cruzi seropositivity,0.0,1.0,False
"Bone mineral density (paediatric, total body less head)",0.0,1.0,False
PR interval in Tripanosoma cruzi seropositivity,0.0,1.0,False
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity,0.0,1.0,False
Response to statins (LDL cholesterol change),0.0,1.0,False
Refractive astigmatism,0.0,1.0,False
Bronchopulmonary dysplasia,0.0,1.0,False
Response to cytadine analogues (cytosine arabinoside),0.0,1.0,False
Psychosis (atypical),0.0,1.0,False
Antibody status in Tripanosoma cruzi seropositivity,0.0,1.0,False
Response to methotrexate in juvenile idiopathic arthritis,0.0,1.0,False
Very long-chain saturated fatty acid levels (fatty acid 20:0),0.0,1.0,False
Urate levels in overweight individuals,0.0,1.0,False
Heart rate response to beta blockers (atenolol monotherapy),0.0,1.0,False
Prudent dietary pattern,0.0,1.0,False
Post bronchodilator FEV1/FVC ratio in COPD,0.0,1.0,False
High-grade serous ovarian cancer,0.0,1.0,False
Serous invasive ovarian cancer,0.0,1.0,False
Blood osmolality (transformed sodium),0.0,1.0,False
Waist-to-hip ratio adjusted for BMI (age <50),0.0,1.0,False
Invasive epithelial ovarian cancer,0.0,1.0,False
Diastolic blood pressure (cigarette smoking interaction),0.0,1.0,False
Body mass index (age <50),0.0,1.0,False
Post bronchodilator FEV1,0.0,1.0,False
Basophil percentage of granulocytes,0.0,1.0,False
Systolic blood pressure (cigarette smoking interaction),0.0,1.0,False
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test),0.0,1.0,False
Neutrophil percentage of white cells,0.0,1.0,False
Alcohol dependence symptom count,0.0,1.0,False
Waist-to-hip ratio adjusted for BMI (age >50),0.0,1.0,False
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test),0.0,1.0,False
GIP levels in response to oral glucose tolerance test (120 minutes),0.0,1.0,False
Breast cancer (estrogen-receptor negative),0.0,1.0,False
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction),0.0,1.0,False
Waist-to-hip ratio adjusted for BMI x sex interaction,0.0,1.0,False
Body mass index x sex x age interaction (4df test),0.0,1.0,False
Fasting blood glucose adjusted for BMI,0.0,1.0,False
Multiple system atrophy,0.0,1.0,False
Rheumatoid arthritis (ACPA-positive),0.0,1.0,False
Heart rate response to recovery post exercise (20 sec),0.0,1.0,False
Heart rate response to recovery post exercise (30 sec),0.0,1.0,False
Heart rate response to recovery post exercise (50 sec),0.0,1.0,False
Heart rate response to recovery post exercise (40 sec),0.0,1.0,False
Non-glioblastoma glioma,0.0,1.0,False
Limited cutaneous systemic scleroderma,0.0,1.0,False
Hyperuricemia,0.0,1.0,False
Iron status biomarkers (total iron binding capacity),0.0,1.0,False
Tumor necrosis factor alpha levels,0.0,1.0,False
Stromal-cell-derived factor 1 alpha levels,0.0,1.0,False
P wave duration,0.0,1.0,False
Elevated serum carcinoembryonic antigen levels,0.0,1.0,False
Serum albumin level,0.0,1.0,False
Serum total protein level,0.0,1.0,False
Chronic obstructive pulmonary disease-related biomarkers,0.0,1.0,False
Total bilirubin levels in HIV-1 infection,0.0,1.0,False
Anti-saccade response,0.0,1.0,False
Heschl's gyrus morphology,0.0,1.0,False
Motion sickness,0.0,1.0,False
Optic cup area,0.0,1.0,False
Iron status biomarkers (iron levels),0.0,1.0,False
Iron status biomarkers (transferrin saturation),0.0,1.0,False
Iron status biomarkers (ferritin levels),0.0,1.0,False
Urate levels in obese individuals,0.0,1.0,False
Serum dimethylarginine levels (asymmetric/symetric ratio),0.0,1.0,False
Age-related nuclear cataracts,0.0,1.0,False
Urate levels in lean individuals,0.0,1.0,False
Sitting height ratio,0.0,1.0,False
TRAIL levels,0.0,1.0,False
Type 1 diabetes and autoimmune thyroid diseases,0.0,1.0,False
Response to serotonin reuptake inhibitors in major depressive disorder,0.0,1.0,False
Nonsyndromic cleft lip with or without cleft palate,0.0,1.0,False
Alzheimer's disease in APOE e4+ carriers,0.0,1.0,False
Cardiac Troponin-T levels,0.0,1.0,False
Systemic lupus erythematosus and Systemic sclerosis,0.0,1.0,False
Lead levels in blood,0.0,1.0,False
Thiazide-induced adverse metabolic effects in hypertensive patients,0.0,1.0,False
Anxiety disorder,0.0,1.0,False
Polychlorinated biphenyl levels,0.0,1.0,False
Complement C3 and C4 levels,0.0,1.0,False
Allergic sensitization,0.0,1.0,False
Clozapine-induced cytotoxicity,0.0,1.0,False
Nasopharyngeal carcinoma (SNP x SNP interaction),0.0,1.0,False
Pursuit maintenance gain,0.0,1.0,False
Age at menopause,0.0,1.0,False
